Protein Intake Considerations Individual requirements vary and clinical assessment is advised
PlexusDx supports this precision-wellness approach through accessible genetic assessment and provider-guided interpretation
For type 2 diabetes, NICE-recommended alternatives include metformin (first-line), SGLT2 inhibitors, DPP-4 inhibitors, and insulin therapy, each with distinct mechanisms and side-effect profiles
If semaglutide isn't delivering expected results after 812 weeks, PlexusDx practitioners can transition you to tirzepatide (a dual GIP/GLP-1 agonist) or GLP-Squared, the dual-compound formulation combining both agents
AMPK AMPKAMPK 1500mg1750mg1,500mg12,250mg123 CTCT SGLT SGLT2 SGLT2SGLT211200500kcal112kg 110mg5mg11 GLP-1 SGLT BSSGLT
Nau The primary outcomes were rates of hypertensive disorders of pregnancy, gestational diabetes, preterm birth and cesarean delivery between the two cohorts